John Galligan

759 total citations
20 papers, 565 citations indexed

About

John Galligan is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Nephrology. According to data from OpenAlex, John Galligan has authored 20 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Nephrology. Recurrent topics in John Galligan's work include Adrenal Hormones and Disorders (4 papers), Bone health and treatments (3 papers) and Thyroid Disorders and Treatments (3 papers). John Galligan is often cited by papers focused on Adrenal Hormones and Disorders (4 papers), Bone health and treatments (3 papers) and Thyroid Disorders and Treatments (3 papers). John Galligan collaborates with scholars based in Australia, United States and Russia. John Galligan's co-authors include R.H. Mortimer, G. R. Cannell, Carolyn A. Richardson, E‐Liisa Laakso, Tess Cramond, R. S. Addison, Carel Pretorius, Brett McWhinney, Donald A. Perry‐Keene and Peter Donovan and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Hepatology and The Journal of Pediatrics.

In The Last Decade

John Galligan

19 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Galligan Australia 12 282 100 79 71 67 20 565
İhsan Üstün Türkiye 14 166 0.6× 50 0.5× 37 0.5× 16 0.2× 112 1.7× 47 668
Cüneyt Özden Türkiye 13 220 0.8× 327 3.3× 32 0.4× 55 0.8× 30 0.4× 57 745
Zahra Yekta Iran 15 146 0.5× 35 0.3× 25 0.3× 69 1.0× 45 0.7× 54 576
Mihail Boyanov Bulgaria 12 363 1.3× 55 0.6× 18 0.2× 39 0.5× 74 1.1× 55 854
Esen Akbay Türkiye 14 159 0.6× 56 0.6× 21 0.3× 16 0.2× 34 0.5× 34 559
Adauto José Cologna Brazil 14 93 0.3× 122 1.2× 22 0.3× 56 0.8× 15 0.2× 72 642
Melanie E. Fields United States 16 120 0.4× 22 0.2× 105 1.3× 166 2.3× 20 0.3× 45 818
Murat Şahin Türkiye 12 82 0.3× 39 0.4× 19 0.2× 29 0.4× 18 0.3× 52 334
Guang-Ran Yang China 9 182 0.6× 30 0.3× 21 0.3× 22 0.3× 15 0.2× 29 459

Countries citing papers authored by John Galligan

Since Specialization
Citations

This map shows the geographic impact of John Galligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Galligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Galligan more than expected).

Fields of papers citing papers by John Galligan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Galligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Galligan. The network helps show where John Galligan may publish in the future.

Co-authorship network of co-authors of John Galligan

This figure shows the co-authorship network connecting the top 25 collaborators of John Galligan. A scholar is included among the top collaborators of John Galligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Galligan. John Galligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Sean, William R. Mulley, Kevan R. Polkinghorne, et al.. (2022). Prognostic Value of Exercise Capacity in Kidney Transplant Candidates. Journal of the American Heart Association. 11(12). e025862–e025862.
2.
Donovan, Peter, et al.. (2015). PTHrP-Mediated Hypercalcemia: Causes and Survival in 138 Patients. The Journal of Clinical Endocrinology & Metabolism. 100(5). 2024–2029. 67 indexed citations
3.
Kapur, Nitin, Ian Brent Masters, Peter S Morris, et al.. (2011). Defining pulmonary exacerbation in children with non‐cystic fibrosis bronchiectasis. Pediatric Pulmonology. 47(1). 68–75. 55 indexed citations
4.
Pretorius, Carel, John Galligan, Brett McWhinney, Scott Briscoe, & Jacobus Ungerer. (2011). Free cortisol method comparison: Ultrafiltation, equilibrium dialysis, tracer dilution, tandem mass spectrometry and calculated free cortisol. Clinica Chimica Acta. 412(11-12). 1043–1047. 34 indexed citations
5.
Tan, Terrence, Linus Chang, Brett McWhinney, et al.. (2010). Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease. Journal of Hepatology. 53(5). 841–848. 72 indexed citations
6.
Laakso, E‐Liisa, Tess Cramond, Carolyn A. Richardson, & John Galligan. (2004). PLASMA ACTH AND β-ENDORPHIN LEVELS IN RESPONSE TO LOW LEVEL LASER THERAPY (LLLT) FOR MYOFASCIAL TRIGGER POINTS. LASER THERAPY. 14(0_Pilot_Issue_2). 0_45–0_53. 3 indexed citations
7.
Mortimer, R.H., et al.. (1996). Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination.. The Journal of Clinical Endocrinology & Metabolism. 81(6). 2247–2249. 88 indexed citations
8.
Laakso, E‐Liisa, Tess Cramond, Carolyn A. Richardson, & John Galligan. (1994). PLASMA ACTH AND β-ENDORPHIN LEVELS IN RESPONSE TO LOW LEVEL LASER THERAPY (LLLT) FOR MYOFASCIAL TRIGGER POINTS. LASER THERAPY. 6(3). 133–141. 71 indexed citations
9.
Yap, Alpha S., R.H. Mortimer, J. M. Jacobi, et al.. (1993). Blunted Parathyroid Response to Correction of Hypercalcemia in Subjects with Squamous Cell Carcinoma. Hormone Research. 40(5-6). 222–226. 1 indexed citations
10.
Yap, Alpha S., R.H. Mortimer, J. M. Jacobi, et al.. (1991). Single-Dose Intravenous Pamidronate Is Effective Alternative Therapy for Paget’s Disease Refractory to Calcitonin. Hormone Research. 36(1-2). 70–74. 6 indexed citations
11.
Mortimer, R.H., et al.. (1991). KETOCONAZOLE AND PLASMA AND URINE STEROID LEVELS IN CUSHING'S DISEASE. Clinical and Experimental Pharmacology and Physiology. 18(8). 563–569. 17 indexed citations
12.
Mortimer, R.H., et al.. (1990). Graves'DISEASE IN PREGNANCY: TSH RECEPTOR BINDING INHIBITING IMMUNOGLOBULINS AND MATERNAL AND NEONATAL THYROID FUNCTION. Clinical Endocrinology. 32(2). 141–152. 56 indexed citations
13.
Gough, Ian, et al.. (1988). The effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism. World Journal of Surgery. 12(4). 463–468. 10 indexed citations
14.
Carrick, Joan, C. C. Pollitt, H. L. Thompson, Sally C Inglis, & John Galligan. (1987). Failure of the administration of ACTH to affect the absorption of colostral immunoglobulin in neonatal foals. Equine Veterinary Journal. 19(6). 545–547. 6 indexed citations
15.
Mortimer, R.H., et al.. (1986). HYPOTHYROIDISM AND GRAVES' DISEASE AFTER MANTLE IRRADIATION: A FOLLOW UP STUDY. Australian and New Zealand Journal of Medicine. 16(3). 347–351. 19 indexed citations
16.
Holt, G. Richard, et al.. (1983). SERUM THYROGLOBULIN AFTER MANTLE IRRADIATION FOR HODGKIN'S DISEASE. Clinical Endocrinology. 18(6). 605–611. 4 indexed citations
17.
Galligan, John, et al.. (1982). A Comparison of Serum Thyroglobulin Measurements and Whole Body 131l Scanning in the Management of Treated Differentiated Thyroid Carcinoma. Australian and New Zealand Journal of Medicine. 12(4). 248–254. 18 indexed citations
18.
Cannell, G. R., et al.. (1982). Extraction of steroids from plasma with reversed phase C18 cartridges. Clinica Chimica Acta. 122(3). 419–423. 21 indexed citations
19.
Galligan, John, et al.. (1960). New Developments in Epoxide Wash-Wear Finishes for Cotton. Textile Research Journal. 30(3). 208–222. 13 indexed citations
20.
Galligan, John, et al.. (1952). Persistent sequelae of bulbar poliomyelitis. The Journal of Pediatrics. 41(5). 549–554. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026